Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Mar 15, 2009 (Vol. 29, No. 6)

Links for Chemists

  • Extensive coverage, tidy organization
  • None
It takes a certain amount of bravado (and perhaps nerve) to name a site Links for Chemists. After all, the field is rather broad, so if you don’t qualify your offerings, they’d darn sure better be as broad as the field you cover. They say it’s not bragging if you are as good as you say you are and that holds for this rather awesome site. I mean, I had to literally wade through the content here to reasonably cover the site. Serving as the chemistry section of the WWW Virtual Library, Links for Chemists is hosted at the University of Liverpool. Main category headings include companies/industry, chemical literature, chemical information, organizations, topics, and links. Each topic has numerous subtopics and these, in turn, each have individual links. Clearly, there is more here than can be covered in a one paragraph review, so interested readers will simply need to check this one out for themselves. I’m sure they won’t be disappointed.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »